An‐Tian Chen
Impact in
-
- Air Quality and Health Impacts
- Climate Change and Health Impacts
-
- Blood Pressure and Hypertension Studies
Papers in
-
- Artificial Intelligence in Healthcare and Education 2
- Oncology 4
- Cancer Cells and Metastasis 2
- Co-authors
- Wei Chen (1 shared paper)Yu-Hui Zhang (1 shared paper)Jian Zhang (1 shared paper)Jianguo Cao (4 shared papers)Chenyu Wang (1 shared paper)Chang Xu (2 shared papers)Xinqing Zhang (1 shared paper)Yimin Luo (2 shared papers)
- Journals
- The Lancet (14 papers)Acta Biochimica et Biophysica Sinica (2 papers)Journal of the American College of Cardiology (2 papers)The Lancet Public Health (1 paper)Aging and Disease (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
An‐Tian Chen
29 papers receiving 9.8k citations
An‐Tian Chen's Hit Papers
Peers
Comparison fields: 5 of 180
- Health, Toxicology and Mutagenesis 588
- Cardiology and Cardiovascular Medicine 596
- Nephrology 192
- Endocrinology, Diabetes and Metabolism 383
- Otorhinolaryngology 96
Countries citing papers authored by An‐Tian Chen
This map shows the geographic impact of An‐Tian Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An‐Tian Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An‐Tian Chen more than expected).
Fields of papers citing papers by An‐Tian Chen
This network shows the impact of papers produced by An‐Tian Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An‐Tian Chen. The network helps show where An‐Tian Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside An‐Tian Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 2923 |
| 2 | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1647 |
| 3 | Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1622 |
| 4 | Global Burden of Cardiovascular Diseases and Risks, 1990-2022 Hit paper breakdown → | 2023 | 912 |
| 5 | Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 650 |
| 6 | Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 642 |
| 7 | Global, regional, and national prevalence of adult overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 428 |
| 8 | Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 296 |
| 9 | Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990–2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2025 | 177 |
| 10 | Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 170 |
| 11 | National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050 Hit paper breakdown → | 2024 | 165 |
| 12 | Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 128 |
| 13 | Global, regional, and national burden of chronic kidney disease in adults, 1990–2023, and its attributable risk factors: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 69 |
| 14 | Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 65 |
| 15 | Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 52 |
| 16 | 2022 | 37 | |
| 17 | Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 35 |
| 18 | 2023 | 23 | |
| 19 | 2024 | 18 | |
| 20 | NF-κB/Twist axis is involved in chysin inhibition of ovarian cancer stem cell features induced by co-treatment of TNF-α and TGF-β. | 2019 | 13 |
About An‐Tian Chen
An‐Tian Chen is a scholar working on Health Informatics, Oncology, Radiology, Nuclear Medicine and Imaging, Pharmacology and Epidemiology, having authored 33 papers that have together received 10.1k indexed citations. Recurring topics across this work include Artificial Intelligence in Healthcare and Education (2 papers), Flavonoids in Medical Research (2 papers), Cancer Cells and Metastasis (2 papers), Cardiac Imaging and Diagnostics (2 papers), Diet and metabolism studies (2 papers), COVID-19 Clinical Research Studies (1 paper), Cardiovascular Function and Risk Factors (1 paper) and Chronic Kidney Disease and Diabetes (1 paper). The work is most often cited by research in Health, Toxicology and Mutagenesis (588 citations), Cardiology and Cardiovascular Medicine (596 citations), Nephrology (192 citations), Endocrinology, Diabetes and Metabolism (383 citations) and Otorhinolaryngology (96 citations). An‐Tian Chen has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Wei Chen, Yu-Hui Zhang, Jian Zhang, Jianguo Cao, Chenyu Wang, Chang Xu, Xinqing Zhang, Jian Zhang, Yimin Luo and Yuhui Zhang. Their work appears in journals such as The Lancet, Acta Biochimica et Biophysica Sinica, Journal of the American College of Cardiology, The Lancet Public Health and Aging and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.